• America's COVID response was always doomed to fail

    4 days ago - By Business Insider

    People protest at Washington's capitol building against the state's extended stay-at-home order on April 19, 2020.
    Reuters/Lindsey Wasson
    The US response to the COVID-19 pandemic has been a disaster compared to other nations.
    This is because our political system values economic output over all other considerations, including public health.
    Leaders in other countries, like New Zealand, have shown how to prioritize public health and have been politically rewarded.
    But given our system, public opinion that favors public health priorities has been swamped by economic concerns among our...
    Read more ...

     

  • Pfizer plans to submit its COVID-19 vaccine for FDA approval in late November

    5 days ago - By Business Insider

    Xinhua/Gil Cohen Magen via Getty Images
    Pfizer and its German partner BioNTech could apply for emergency-use authorization for their COVID-19 vaccine in late November, Pfizer said on Friday.
    The companies would submit their application to the FDA in the third week of November if late-stage human trials go well, Pfizer said.
    This is the first time a leading vaccine developer in the West has given a specific timeline for an emergency use authorization application.
    Pfizer's announcement means there is no chance its vaccine will be authorized for use before the election on November 3.
    Visit...
    Read more ...

     

  • Remdesivir proved to be the first useful tool we have in treating COVID-19 patients. Now, the US government wants to find out more about how it could be supercharged with other drugs

    5 days ago - By Business Insider

    FILE
    Reuters
    Several leading coronavirus clinical trials are focusing on testing experimental combinations of medicine to treat COVID-19.
    These studies are building on top of the early success of remdesivir, an antiviral drug developed by Gilead Sciences that helped hospitalized COVID-19 patients recover modestly faster.
    On Friday, the US National Institutes of Health launched a massive study that will test three drugs seeking to tamp down a runaway immune response in COVID-19 patients. These drugs will be tested in addition to giving remdesivir to the trial participants.
    For more stories...
    Read more ...

     

  • This Italian town has just two residents, but they insist on wearing masks

    5 days ago - By CNN

    They're the sole inhabitants of Nortosce, but Giovanni Carilli and Giampiero Nobil aren't taking any chances when it comes to upholding Italy's strict Covid-19 rules.
    Read more ...

     

  • European stocks rebound as higher chance of US stimulus offsets gloom over explosion in COVID-19 cases

    5 days ago - By Business Insider

    AP/Richard Drew
    European stocks recovered on Friday despite an alarming rise in cases of Covid-19 across the region, driven by optimism that US lawmakers could reach agreement on fiscal stimulus. The UK's FTSE 100 rose 0.6%, Germany's DAX rose 0.5%, and the Euro Stoxx 50 added 0.7% in early trading. UK Prime Minister Boris Johnson is expected to provide an update later Friday on Brexit negotiations. The British Foreign Secretary has signaled that the country is close to a deal with the EU. "The increasingly higher risks of COVID-19, US fiscal stimulus impasse, and the impending US...
    Read more ...

     

  • Remdesivir, the only antiviral authorized for COVID-19 in US, does not improve chances of survival, a massive WHO study found

    5 days ago - By Business Insider

    Remdesivir has an emergency use authorization for all hospitalized patients with COVID-19 in the US.
    Reuters
    A World Health Organization study of more than 2,750 COVID-19 patients suggested that antiviral drug Remdesivir has "little or no effect" on survival.
    The Solidarity trial, which has not yet been peer-reviewed, found Remdesivir did not "substantially affect mortality," reduce the need to ventilate patients, or shorten hospital stays.
    President Donald Trump received the antiviral drug as part of his COVID-19 treatment after he tested positive for the virus.
    Remdesivir is the only...
    Read more ...